These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7792024)

  • 21. Study of hyperlipidemia in adults with nephrotic syndrome.
    Khanna UB; Nerurkar SV; Almeida AF; Taskar SP; Acharya VN
    J Postgrad Med; 1985 Jul; 31(3):140-5. PubMed ID: 4087215
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipid peroxidation and the system of antioxidant protection in patients with chronic glomerulonephritis and normal kidney azoturic function].
    Riabov SI; Kulikova AI; Tugusheva FA; Zubina IM; Kozlov VV
    Ter Arkh; 1995; 67(12):33-7. PubMed ID: 8820054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of blood soluble and cell surface tumor necrosis factor receptors in childhood nephrotic syndrome.
    Tain YL; Liu CA; Yang KD
    Pediatr Nephrol; 2002 Nov; 17(11):926-32. PubMed ID: 12432436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood fatty acids in various pathologic conditions. Apropos of 156 observations].
    Warembourg H; Biserte G; Bertrand M; Jaillard J; Sezille G
    Presse Med (1893); 1967 Mar; 75(11):523-6. PubMed ID: 6019860
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA; Davies RW
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Questions about a case of congenital nephrotic syndrome].
    Watine J
    Ann Biol Clin (Paris); 1999; 57(1):110. PubMed ID: 9920977
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipoprotein abnormalities in adult nephrotic syndrome.
    Ongajyooth L; Sirisalee K; Laohaphand T; Parichatiganond P; Shayakul C; Nilwarangkur S
    J Med Assoc Thai; 1993 Sep; 76(9):512-20. PubMed ID: 7964258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome.
    Ishikura K; Ikeda M; Hamasaki Y; Hataya H; Nishimura G; Hiramoto R; Honda M
    Nephrol Dial Transplant; 2008 Aug; 23(8):2531-6. PubMed ID: 18258739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M; Anarat A; Bayazit AK; Noyan A; Ozel A; Anarat R; Aydingülü H; Dikmen N
    Turk J Pediatr; 2002; 44(1):40-4. PubMed ID: 11858378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
    Wanner C; Böhler J; Eckardt HG; Wieland H; Schollmeyer P
    Clin Nephrol; 1994 Mar; 41(3):138-43. PubMed ID: 8187355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome.
    Ece A; Atamer Y; Gürkan F; Bilici M; Koçyiğit Y
    Nephrology (Carlton); 2004 Dec; 9(6):366-73. PubMed ID: 15663638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent findings on the pathophysiology of hyperlipoidemia in the nephrotic syndrome].
    PEZOLD FA
    Dtsch Arch Klin Med; 1959; 205():640-67. PubMed ID: 14432482
    [No Abstract]   [Full Text] [Related]  

  • 34. Abnormalities of homocysteine and B vitamins in the nephrotic syndrome.
    Podda GM; Lussana F; Moroni G; Faioni EM; Lombardi R; Fontana G; Ponticelli C; Maioli C; Cattaneo M
    Thromb Res; 2007; 120(5):647-52. PubMed ID: 17276499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy.
    De Smet E; Rioux JP; Ammann H; Déziel C; Quérin S
    Nephrol Dial Transplant; 2009 Sep; 24(9):2938-40. PubMed ID: 19509024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of edema formation in the nephrotic syndrome.
    Donckerwolcke RA; Vande Walle JG
    Kidney Int Suppl; 1997 Mar; 58():S72-4. PubMed ID: 9067949
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lipid disorders in lipoid nephrosis].
    LAGRUE G
    Bull Med; 1957 Apr; 71(5):162-3. PubMed ID: 13446602
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma platelet activating factor in nephrotic syndrome.
    Camici M; Sagripanti A
    Minerva Med; 2001 Oct; 92(5):325-7. PubMed ID: 11675576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiated diagnosis of nephrotic syndrome.
    Brandis M
    Klin Padiatr; 1982; 194(3):158-61. PubMed ID: 7132222
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperlipidaemia and cardiovascular disease.
    Sussekov AV
    Curr Opin Lipidol; 1999 Dec; 10(6):635-9. PubMed ID: 10680059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.